Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV000011729 | SCV000245528 | pathogenic | Renpenning syndrome | 2013-02-05 | criteria provided, single submitter | clinical testing | This variant has been previously reported as disease-causing and was found once in our laboratory maternally inherited in a 40-year-old male with intellectual disability, autism, dysmorphic features, strabismus |
Gene |
RCV000599325 | SCV000709914 | pathogenic | not provided | 2024-08-29 | criteria provided, single submitter | clinical testing | Published functional studies demonstrate a damaging effect: loss of the YxxPxxVL motif that is essential for binding with the spliceosomal protein U5-15kD (PMID: 24781215); Frameshift variant predicted to result in protein truncation, as the last 52 amino acids are replaced with 12 different amino acids, and other loss-of-function variants have been reported downstream in the Human Gene Mutation Database (HGMD); Not observed at significant frequency in large population cohorts (gnomAD); Also known as c.641insC; This variant is associated with the following publications: (PMID: 9545405, 26633545, 24781215, 27535533, 15024694, 24077912) |
Ce |
RCV000599325 | SCV001501106 | pathogenic | not provided | 2021-06-01 | criteria provided, single submitter | clinical testing | |
Greenwood Genetic Center Diagnostic Laboratories, |
RCV000011729 | SCV002525442 | pathogenic | Renpenning syndrome | criteria provided, single submitter | research | ||
OMIM | RCV000011729 | SCV000031961 | pathogenic | Renpenning syndrome | 2004-04-01 | no assertion criteria provided | literature only |